Loading...
Loading...
Among the 4 tracked institutional investors we monitor, TRAW (TRAWS PHARMA INC) is held with a combined value of $164.08K across 123,040 shares. The largest holder is VANGUARD GROUP INC with a position worth $98.60K (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$164.08K
Total Shares Held
123,040
Institutional Holders
4
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $98.60K | 0.00% | New |
| 2 | STATE STREET CORP | $47.22K | 0.00% | - |
| 3 | BlackRock, Inc. | $18.22K | 0.00% | - |
| 4 | FMR LLC | $42 | 0.00% | +1050.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of TRAW with a position worth $98.60K, representing 0.00% of their portfolio. In total, 4 institutional investors hold TRAW with a combined value of $164.08K.
In the most recent quarter, 1 fund opened a new position in TRAW. Additionally, 1 increased their holdings.
Institutional investors hold $164.08K worth of TRAW stock across 4 positions. The largest institutional holder is VANGUARD GROUP INC with $98.60K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TRAW, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TRAW positions.